Rationale: Reactive oxygen species (ROS) are implicated in the development of cardiovascular disease, and oxidants are important signaling molecules in many cell types. Recent evidence suggests that localized subcellular compartmentalization of ROS generation is an important feature of ROS signaling. However, mechanisms that transduce localized subcellular changes in redox status to functionally relevant changes in cellular processes such as Ca 2؉ influx are poorly understood.
O xidative and reductive biochemical processes are integral components of cellular biology. However, disruption of cellular redox status beyond physiological parameters is correlated with disorders ranging from cardiovascular disease to neurodegeneration to cancer. The cardiovascular system appears to be particularly sensitive to perturbations in redox balance with increased oxidative stress implicated in the development of cardiovascular diseases including heart failure, atherosclerosis, stroke, and hypertension. [1] [2] [3] [4] [5] The apparent sensitivity of the cardiovascular system to redox imbalance may reside in the relative functional importance of redox signaling under physiological conditions. Redox biochemistry has been studied extensively in the vasculature, 4,6 -9 with specialized subcellular compartmentalization, regulation, and generation of reactive oxygen species (ROS) emerging a common theme. 10 -12 However, mechanisms that transduce localized subcellular changes in redox signaling to functionally relevant changes in cellular processes such as Ca 2ϩ influx are less clear.
Peripheral arterial resistance is determined by the contractile state of arterial smooth muscle, which is tightly coupled to Ca 2ϩ influx through L-type voltage-dependent Cav1.2 Ca 2ϩ channels. [13] [14] [15] Total internal reflection fluorescence (TIRF) microscopy has been used to image L-type Ca 2ϩ channel (Ca 2ϩ sparklet) activity in arterial smooth muscle cells with high temporal and spatial resolution. 16 -19 Using this approach, a high-activity mode of Cav1.2 Ca 2ϩ channel function was identified. These studies revealed that high-activity Ca 2ϩ sparklets resulted from spatially restricted enhancement of Cav1.2 Ca 2ϩ channel function by protein kinase (PK)C␣. PKC␣-dependent Ca 2ϩ sparklet activity was found to be necessary for normal arterial function. 16, 19, 20 In addition, increased PKC␣-dependent Ca 2ϩ sparklet activity was associated with altered gene expression and arterial dysfunction in exper-imental models of hypertension. 19, 20 Despite these intriguing observations, the molecular mechanisms underlying high-activity localized PKC␣-dependent L-type Ca 2ϩ channel function are poorly understood.
Using a novel TIRF imaging-based approach, we identified and characterized a mechanism that functionally links local oxidant signaling to sustained colocalized L-type Ca 2ϩ channel activity. We demonstrate for the first time that highly localized subplasmalemmal generation of endogenous ROS precede and colocalize with enhanced L-type Ca 2ϩ channel activity in cerebral arterial smooth muscle. Consistent with this observation, ROS increased L-type Ca 2ϩ channel sparklet activity via activation of PKC␣ and increased arterial tone in an L-type Ca 2ϩ channel-dependent fashion. Taken together, our data suggest that local oxidative activation of PKC␣-dependent L-type Ca 2ϩ influx represents a functionally relevant convergence of oxidant and Ca 2ϩ signaling pathways in cerebral arterial smooth muscle with physiological and pathological implications.
Methods
Male Sprague-Dawley rats were euthanized with sodium pentobarbital (200 mg/kg IP) as approved by the Institutional Animal Care and Use Committee of Colorado State University. Smooth muscle cells were isolated from basilar and cerebral arteries.
Arteries for intact tissue experiments were cannulated, pressurized with bicarbonate-based physiological saline solution, and superfused with aerated physiological saline solution at 37°C. To block the effects of endothelial-derived nitric oxide, we used the nitric oxide synthase inhibitor N G -nitro-L-arginine (L-NNA) (300 mol/L). Intravascular pressure was maintained at 80 mm Hg, and inner diameter was continuously monitored.
We used the conventional whole-cell patch-clamp technique to voltage clamp freshly isolated arterial myocytes. L-type Ca 2ϩ channel sparklets were recorded with a through-the-lens TIRF system with ϫ60 (numeric apertureϭ1.49) and ϫ100 (numeric apertureϭ1.45) TIRF oil immersion objectives. All TIRF experiments were performed in the presence of thapsigargin (1 mol/L). To monitor Ca 2ϩ influx, myocytes were loaded with the Ca 2ϩ indicator fluo-5F (200 mol/L) via dialysis through the patch pipette. L-type Ca 2ϩ channel sparklets were visualized and recorded at a holding potential of Ϫ70 mV with elevated external [Ca 2ϩ ] (20 mmol/L) to facilitate the detection of Ca 2ϩ sparklet events and provide fluorescent signals of sufficient amplitude 17 to permit quantal analysis of Ca 2ϩ sparklet activity. Fluo-5F fluorescence was converted to [Ca 2ϩ ] and analyzed as previously reported using a custom automated algorithm. 17,21 Ca 2ϩ sparklet activity was quantified 17,18 by calculating the nP s of each sparklet site, where n is the number of quantal levels and P s is the probability that a given Ca 2ϩ sparklet site is active. As with previous reports, 17,18 Ca 2ϩ sparklet activity was bimodally distributed with sites of low activity (nP s 0 to 0.2) and high activity (nP s Ͼ0.2). TIRF microscopy was also used to visualize subplasmalemmal ROS generation in isolated arterial myocytes using the cell-permeant ROS indicator 5-(and-6)-chloromethyl-2Ј7Ј-dichlorodihydrofluorescein diacetate acetyl ester (DCF) (10 mol/L).
For our immunofluorescence studies, we used a mouse monoclonal PKC␣ antibody (Abcam) with an Alexa Fluor 488 -conjugated rabbit anti-mouse secondary antibody on freshly prepared myocytes. Fluorescence was undetectable in control experiments where either the primary or the secondary antibody was omitted (data not shown). Membrane and cytosolic PKC␣-associated fluorescence was quantified by measuring the intensity of pixels above a set threshold. We determined the ratio of plasma membrane to cytosolic PKC␣-associated fluorescence and used this as an indicator of PKC␣ translocation and activity. 19, 22 Normally distributed data are presented as the meansϮSEM with comparisons performed using parametric tests. For bimodally distributed Ca 2ϩ sparklet activity (ie, nP s ) datasets, comparisons were performed using nonparametric tests. Arithmetic means of nP s datasets are indicated in the figures (solid red horizontal lines) for nonstatistical purposes. Probability values of less than 0.05 were considered significant, and asterisks (*) in the figures indicate a significant difference between groups.
An expanded Methods section is available in the Online Data Supplement at http://circres.ahajournals.org.
Results
To test the overall hypothesis that ROS regulate L-type Ca 2ϩ channel activity in cerebral arterial smooth muscle, we formulated 4 specific requisite criteria: (1) exogenous ROS should increase arterial tone in a L-type Ca 2ϩ channeldependent manner; (2) exogenous ROS should stimulate Ca 2ϩ sparklet activity in isolated myocytes; (3) inhibition of endogenous ROS generation should limit arterial contraction and prevent stimulation of Ca 2ϩ sparklet activity; and (4) endogenous ROS production should colocalize with Ca 2ϩ sparklet activity.
Exogenous ROS Increase Arterial Tone in Pressurized Cerebral Arteries
We examined the effects of ROS on arterial smooth muscle function by exposing pressurized cerebral arteries (80 mm Hg at 37°C) to the ROS-generating system xanthine oxidase (XO) (0.2 mU/mL) plus hypoxanthine (HX) (250 mol/L) ( Figure 1 ). The nitric oxide synthase inhibitor L-NNA (300 mol/L) was present to preclude contractile responses from ROS-dependent reductions in nitric oxide. 23 Following the development of a stable level of myogenic tone (24.8Ϯ2.5%, nϭ8 arteries), we exposed arteries to HX followed by XO/HX and monitored changes in luminal diameter. Although HX alone had no effect (PϾ0.05, nϭ8 arteries), addition of XO reversibly reduced luminal diameter by 18.1Ϯ6.9 m, corresponding to a 10.7Ϯ4.1% increase in arterial tone (Figure 1A and 1B 17 ,18 Accordingly, we tested the effects of XO/HX on PKC␣ activation in arterial myocytes with immunofluorescence by using the level of plasma membrane-associated PKC␣ as an indicator of activation ( Figure 3A) . 19, 22 Under control conditions (HX; 250 mol/L), PKC␣-associated fluorescence was diffusely cytosolic with few discrete elevations along the plasma membrane. In contrast, following XO (2 mU/mL)ϩHX (250 mol/L) exposure, and indicative of activation, PKC␣-associated fluorescence was characterized by prominent focal elevations near (Յ1 m) the plasma membrane ( Figure 3B ; PϽ0.05, nϭ15 cells). Our PKC␣ immunofluorescence data suggest that ROS could increase L-type Ca 2ϩ channel sparklet activity by activating PKC␣. To examine this possibility, we tested the effects of XO/HX on Ca 2ϩ sparklets in the presence of the PKC inhibitor Gö6976 (100 nmol/L). In contrast to experiments in the absence of Gö6976 (eg, Figure 2 ), XO/HX had no effect on Ca 2ϩ sparklet activity or density following inhibition of PKC␣ (Figure 3C and 3D; PϾ0.05, nϭ5 cells). These data suggest that ROS stimulate L-type Ca 2ϩ channel sparklet activity via activation of PKC␣.
NADPH Oxidase Inhibition Prevents Angiotensin II-Dependent Stimulation of L-Type Ca

2؉
Channels and Arterial Constriction
Angiotensin (Ang) II stimulates ROS-generating NADPH oxidase signaling complexes. Therefore, we used Ang II to examine the role of endogenous ROS generation on Ca Ang II produces endothelium-independent arterial constriction via stimulation of AT 1 receptors (also see Figure  5A ). 27,28 Similar to our Ca 2ϩ sparklet experiments, inhibition of NADPH oxidase with apocynin (and PKC with Gö 6976) abolished contractile responses to Ang II (1 nmol/L; Figure 5B through 5D; PϽ0.05, nϭ3 arteries). Taken together, these data support our hypothesis that generation of endogenous ROS is necessary for AT 1 -dependent Ang II stimulation of L-type Ca 2ϩ channels and arterial constriction.
Ang II Stimulates L-Type Ca 2؉ Channel Sparklet Activity via Local Production of ROS
If generation of endogenous ROS were necessary for Ang II-dependent stimulation of L-type Ca 2ϩ channels, then sites of Ca 2ϩ sparklet activity should colocalize with endogenous sites of ROS production. We used TIRF microscopy to visualize subplasmalemmal generation of ROS in response to Ang II. Isolated myocytes were loaded with the ROS indicator DCF (10 mol/L). Figure 6A shows TIRF images of DCF fluorescence under control conditions and after application Ang II (100 nmol/L; both in Ca 2ϩ -free buffer). Interestingly, discrete sites (puncta) of elevated DCF fluorescence were apparent under control conditions (0.006Ϯ0.002 puncta per m 2 ) and increased in number Ϸ3. 5 Having demonstrated that increased ROS production (as with Ca 2ϩ sparklet activity) in response to Ang II is localized, we developed an experimental approach to visualize the spatial distributions of ROS generation (with DCF) and L-type Ca 2ϩ channel sparklet activity (with fluo-5F) in the same cell. First, we loaded isolated myocytes with DCF in Ca 2ϩ free buffer (as above), placed a patch pipette on the cell, formed a G⍀ seal (ie, established the cell-attached patch configuration), and applied Ang II (100 nmol/L). On visualization of sites of punctate elevations in DCF fluorescence ( Figure 7A , panel 1, time course i), negative pressure was applied to the interior of the pipette to rupture the plasma membrane (ie, establish the whole-cell patch configuration), thus dialyzing the cell with fluo-5F. Next, we replaced the Ca 2ϩ -free external solution with one containing 20 mmol/L Ca 2ϩ and monitored for Ca 2ϩ sparklet activity. Strikingly, we found that the sites of ROS generation colocalized with high-activity (nP s ϭ0.56Ϯ0.26) Ca 2ϩ sparklet sites ( Figure 7A , panel 2, time course ii; nϭ6 sites from 5 cells). Although Ca 2ϩ sparklet sites were always associated with a preceding site of ROS generation, we did observe 3 sites of ROS generation that were not associated with subsequent Ca 2ϩ sparklet activity (data not shown; nϭ3 ROS sites in 7 cells).
To further establish the proximity of punctate ROS generation and Ca 2ϩ sparklet activity, we thresholded (mean basal fluo-5F fluorescence plus 3 times its SD) our fluo-5F fluorescence images to isolate Ca 2ϩ sparklet fluorescence and merged them ( Figure 7A , panel 3) with the DCF images ( Figure 7A, panel 1) . As evident in the composite image ( Figure 7A , panel 4), sites of punctate ROS generation and Ca 2ϩ sparklet activity were closely apposed. Indeed, the average distance between the peaks of ROS puncta and Ca 2ϩ sparklet sites was Ͻ1 m (0.91Ϯ0.24 m; nϭ6 sites from 5 cells). To place this distance into perspective, the average cell area imaged during these experiments was 99.2Ϯ13.7 m 2 and the probability, by chance alone, that we would observe 6 ROS puncta and 6 Ca 2ϩ sparklet sites Ϸ1 m apart in this area is Ͻ1 in 1 000 000 (see the Online Data Supplement for details). From these data, we conclude that sites of ROS generation precede and colocalize with sites of L-type Ca 2ϩ channel sparklet activity.
Discussion
In this study, we combined TIRF imaging with conventional techniques to test the hypothesis that ROS regulate L-type sparklet activity. These observations support a model (see Figure 7D ) of local oxidative regulation of Ca 2ϩ influx where vasoconstrictors coupled to NAPDH oxidase (eg, Ang II) induce discrete sites of ROS generation, resulting in activation of adjacent PKC␣ molecules. PKC␣ activation in turn promotes localized L-type Ca 2ϩ channel (ie, sparklet) activity, resulting in increased Ca 2ϩ influx and arterial contraction. To the best of our knowledge, our model provides the first experimentally based mechanistic framework whereby local changes in redox signaling result in changes in Ca 2ϩ influx and arterial function.
ROS impairment of endothelial function leads to increased arterial tone. 23, 29 Our observation that XO/HX constricts cerebral arteries (presumably via PKC activation) after endothelial nitric oxide synthase inhibition with L-NNA suggests that ROS also increase tone through smooth muscle-specific mechanisms. Activation of arterial smooth muscle PKC by ROS could induce contraction by a minimum of 4 non-mutually exclusive mechanisms: (1) increased localized L-type Ca 2ϩ channel sparklet activity as characterized here; (2) modulation of other plasmalemmal ion channels (eg, inhibition of hyperpolarizing potassium channels 30 or activation of depolarizing transient receptor potential channels 31 ; (3) decreased hyperpolarizing ryanodine receptor-dependent Ca 2ϩ spark activity 32 ; and (4) sensitization of the arterial smooth muscle contractile apparatus to Ca 2ϩ . 33 The discrete subcellular nature of Ang II-dependent ROS generation demonstrated here suggests that the relationship between ROS and these diverse regulatory mechanisms could be determined in part by coincident localization of ROSgenerating and smooth muscle regulatory signaling complexes. In addition, differential subcellular distributions of signaling complexes and ROS-generating enzymes could account for contradictory data regarding the effect of ROS on arterial tone (ie, contraction 34 versus relaxation 35 ).
PKC stimulation of NADPH oxidase is well-documented. 36,37 However, reciprocal activation of PKC by ROS in arterial smooth muscle, as shown here, has not been reported. Oxidative activation of PKC␣ leads to sustained cofactorindependent kinase activity. 25,38 Sustained PKC activity is consistent with the observation that established high-activity L-type Ca 2ϩ channel sparklet sites are abolished by PKC inhibition. 17 Application of exogenous ROS did not produce a uniform translocation of PKC␣ to the plasma membrane. Rather, accumulation of PKC␣ at the plasma membrane was irregular with punctate elevations in PKC␣-associated fluorescence (Figure 3) . Similarly, the increase in Ca 2ϩ sparklet site density by exogenous ROS was far less than predicted if ROS exposure resulted in a generalized nonspecific translocation of PKC to the plasma membrane. Importantly, previous work in arterial smooth muscle cells has shown that the scaffold protein AKAP150 is necessary for punctate membrane localization of PKC␣ and Ca 2ϩ sparklet activity. 19 In this context, our observation that ROS exposure produced spatially restricted PKC␣-dependent Ca 2ϩ sparklet activity suggests that although ROS may induce PKC activation, additional components such as AKAP150 are necessary for efficient targeting of the kinase to the plasma membrane to stimulate localized L-type Ca 2ϩ channel activity.
Our imaging of punctate sites of endogenous ROS generation in isolated cells with DCF indicates that stimulation of L-type Ca 2ϩ channels by ROS would also be restricted by the localized nature of ROS production and not just by limited membrane targeting of PKC␣ per se. However, PKC phosphorylation of p47phox is an important step in the initial activation of NADPH oxidase by Ang II. 9, 39 Thus, PKC regulation of L-type Ca 2ϩ channels likely involves (at least) 2 events where PKC first stimulates the production of NADPH oxidase-derived ROS, which in turn oxidatively activates PKC␣ resulting in enhanced Ca 2ϩ sparklet activity. Our data do not address this hypothesis directly. However, during our ROS imaging experiments the external solution was free of Ca 2ϩ and we incubated the cells with the sarcoplasmic reticulum Ca 2ϩ -ATPase inhibitor thapsigargin. Thus, neither Ca 2ϩ entry into the cell nor release from of Ca 2ϩ from internal stores appears to be necessary for ROS generation in response to Ang II in isolated arterial myocytes.
In combination with supporting data, our sequential ROS/ Ca 2ϩ imaging experiments provide compelling evidence suggesting that endogenous ROS locally regulate L-type Ca 2ϩ channel activity. Using this unique approach, we found that ROS production preceded and colocalized with sites of L-type Ca 2ϩ channel sparklet activity (respective peaks Ͻ1 m apart). It is possible that the molecular components necessary for ROS production and L-type Ca 2ϩ channel activity share the same subcellular location but are independent and not functionally linked. However, this possibility is rendered unlikely by our data showing that: (1) exogenous ROS promote PKC␣ activation and translocation to the plasma membrane; (2) exogenous ROS stimulate PKCdependent Ca 2ϩ sparklet activity; and (3) inhibition of endogenous ROS generation with apocynin abolished stimulation of Ca 2ϩ sparklets by Ang II. Note that whether apocynin is acting as a bone fide inhibitor of NADPH oxidase or as an antioxidant 40 does not contradict our overall hypothesis that localized generation of ROS stimulate L-type Ca 2ϩ channel activity.
To conclude, in this study, we provide compelling evidence in support of the hypothesis that local changes in redox status are transduced to sustained Ca 2ϩ influx through L-type Ca 2ϩ channels (ie, high-activity Ca 2ϩ sparklets). The implications and questions raised by our observations are intriguing. What molecular components are necessary for the formation of this novel signalosome? Are other signaling pathways subject to or influenced by similar local regulation 
Novelty and Significance
What Is Known?
• Reactive oxygen species (ROS) are important signaling molecules in cardiovascular cells.
• Because of their reactive nature and as a mechanism conferring specificity, ROS production is thought to be localized for them to function effectively.
• Highly localized L-type calcium channel activity has been observed in arterial smooth muscle cells and shown to contribute to arterial contraction.
What New Information Does This Article Contribute?
• Exogenous ROS increase localized protein kinase C-dependent L-type calcium channel activity in isolated arterial smooth muscle cells and constrict intact arteries in an L-type calcium channeldependent manner.
• Generation of endogenous ROS by NADPH oxidase is necessary for stimulation of L-type calcium channels and arterial contraction in response to the vasoconstrictor angiotensin II.
• Angiotensin II induces punctate sites of ROS generation that precede and colocalize with L-type calcium channel activity in isolated arterial smooth muscle cells.
ROS and calcium are essential components of arterial function under physiological and pathophysiological conditions. However, the relationship between these 2 signaling modalities is unclear.
In this study, we investigated the functional and spatial relationship between ROS and L-type calcium channels, a major source of cytoplasmic calcium in arterial smooth muscle. We found that ROS stimulated local sites of L-type calcium channel activity in isolated arterial smooth muscle cells and induced contraction of intact arterial segments. Using a novel imagingbased approach, we visualized punctate sites of endogenous ROS formation in isolated arterial smooth muscle cells. We also show, for the first time, that the spatial distribution of these ROS puncta overlaps with that of local L-type calcium channel activity. These observations indicate that discrete sites of ROS generation are functionally and spatially coupled to local calcium influx through single L-type calcium channels in arterial smooth muscle cells. ROS are widely implicated in the pathogenesis of hypertension. Because the relationship between ROS and L-type calcium channels results in increased channel function, our findings should provide mechanistic insight into events underlying increased calcium influx during hypertension and lead to the development of new rational therapies for managing and preventing disease.
1
Supplemental Material Detailed Methods
Isolation of cerebral arterial myocytes
Male Sprague-Dawley rats (250 to 350 g; Harlan, Indianapolis, IN) were euthanized with sodium pentobarbital (200 mg/kg intraperitoneally; Fort Dodge Animal Health, Fort Dodge, IA) in accordance with institutional guidelines and approved by the Institutional Animal Care and Use Committee of Colorado State University. Smooth muscle cells were prepared from basilar and cerebral arteries. Arteries were removed, cleaned of connective tissue, and placed in ice-cold Ca 2+ -free buffer containing (in mmol/L): 140 NaCl, 5 KCl, 2 MgCl 2 , 10 glucose, and 10 HEPES (adjusted to pH 7.4 with NaOH). Arterial segments were incubated for 15 minutes at 37°C in Ca 2+ -free buffer supplemented with papain (10 U/mL; Worthington Biochemical, Lakewood, NJ) and dithiothreitol (1 mg/mL) followed by a second incubation (15 minutes at 37°C) in Ca 2+ -free buffer supplemented with Sigma Blend collagenases Types F and H (0.5 mg/mL each). Arteries were then washed with and placed in unsupplemented Ca 2+ -free buffer and kept on ice for 30 minutes after which gentle trituration with a fire-polished Pasteur pipette was used to create a cell suspension. Cells were used within 6 hours of dispersion.
Intact arterial diameter measurements
Cerebral arteries for intact tissue experiments were isolated and stored in ice-cold MOPS buffer containing (in mmol/L): 145 NaCl, 5 KCl, 1 MgSO 4 , 2.5 CaCl 2 , 1 KH 2 PO 4 , 0.02 EDTA, 2 pyruvate, 5 glucose, 1% bovine serum albumin, and 3 MOPS (adjusted to pH 7.4 with NaOH). Arteries were cleaned of connective tissue and transferred to a vessel chamber (Living Systems, Burlington, VT). One end of the artery was cannulated with a glass micropipette and secured with monofilament thread. Luminal contents were gently rinsed and the other end was cannulated and secured. Arteries were pressurized to 10 mmHg with a bicarbonate-based physiological saline solution (B-PSS) containing (in mmol/L): 119 NaCl, 4.7 KCl, 1.8 CaCl 2 , 1.2 MgSO 4 , 24 NaHCO 3 , 0.2 KH 2 PO 4 , 10.6 glucose, 1.1 EDTA, and superfused (5 mL/min) with warmed B-PSS (37°C) aerated with a normoxic gas mixture (21% O 2 , 6% CO 2 , balance N 2 ). To block the effects of endothelial-derived nitric oxide, the nitric oxide synthase inhibitor N G -nitro-L-arginine (300 µmol/L) was included in all B-PSS superfusates.
Following a 15-minute equilibration period, intraluminal pressure was increased to 110 mmHg, the arteries were stretched to remove bends, and the pressure was reduced to 10 mmHg for an additional 15-minute equilibration period. Intravascular pressure was increased to 80 mmHg and inner diameter was continuously monitored using video microscopy and edge-detection software (Ionoptix, Milton, MA). To assess viability of the preparation, arteries were exposed to isotonic B-PSS containing 60 mmol/L KCl. Experiments began after a stable level of myogenic tone was obtained at 80 mmHg and were terminated by superfusing with Ca 2+ -free B-PSS to obtain the passive diameter of the artery. Xanthine oxidase (XO; 0.2 mU/mL) and hypoxanthine (HX; 250 µmol/L) were added to warm B-PSS (37°C) at the onset of experimentation to minimize excessive accumulation of reactive oxygen species. The L-type Ca 2+ channel blocker diltiazem (10 µmol/L) was included in some experiments. Arterial tone was calculated as the percentage difference in active luminal diameter versus passive luminal diameter. For our experiments with Ang II (1 nmol/L), apocynin (25 µmol/L), and Gö6976 (100 nmol/L), in addition to N G -nitro-Larginine (300 µmol/L), we included the AT2 receptor antagonist PD 123319 (1 µmol/L) to preclude endothelial AT2 receptor responses.
Electrophysiology
We used the conventional whole-cell patch-clamp technique to control isolated arterial myocyte membrane potential using an Axopatch 200B amplifier (Molecular Devices, Sunnyvale, CA). Freshly prepared cerebral arterial myocyte suspensions (in Ca XO (2 mU/mL) and HX (250 µmol/L) were combined at the onset of experimentation. Note that we used a greater amount of XO (2 mU/mL) in our electrophysiological experiments performed at room temperature (≈ 22°C) than in our intact artery experiments (0.2 mU/mL) performed at 37°C to compensate for differences in solution transit time and temperature-dependent effects on XO activity 3 . Drug treatments (XO/HX and angiotensin II) in the presence or absence of inhibitors (Gö6976, apocynin, or ZD7155) were allowed to progress between 5 and 10 minutes. Only recordings with stable GΩ seals were analyzed. ] i value at or above the amplitude threshold and the location of the highest-amplitude pixel within this grid was defined as the location (peak) of the Ca 2+ sparklet site.
L-type Ca
We performed a quantal analysis of Ca 2+ sparklet activity 1, 2 using histograms generated from the amplitudes of individual Ca 2+ sparklet events. The resulting histograms were fitted with the multicomponent Gaussian function 
Detection of localized reactive oxygen species generation
TIRF microscopy was also to visualize subplasmalemmal generation of reactive oxygen species (ROS) in isolated arterial myocytes. Cells were loaded in Ca 2+ -free buffer supplemented with the cell-permeant ROS indicator 5-(and-6)-chloromethyl-2'7'-dichlorodihydrofluorescein diacetate acetyl ester (DCF; 10 µmol/L; Invitrogen, Carlsbad, CA) for 20 minutes at room temperature. Following removal of excess DCF with Ca 2+ -free buffer, excitation of subplasmalemmal intracellular DCF was achieved with a 491 nm laser and excitation and emission light was separated with appropriate filters. Similar to Ca 2+ sparklet sites 2 , for an area of elevated DCF fluorescence to be considered a site of increased ROS generation, a grid of 3 x 3 contiguous pixels had to have a fluorescent amplitude equal to or larger than the mean basal DCF fluorescence plus three times its standard deviation and the location of the highest-amplitude pixel within this grid was defined as the location (peak) of the site. ROS puncta densities (ROS puncta per µm 2 ) were calculated by dividing the number of sites detected by the area of cell membrane visible in the TIRF images.
Sequential imaging of reactive oxygen species generation and Ca 2+ sparklet activity
To examine the spatial distribution of ROS generation and Ca 2+ sparklet activity in isolated arterial myocytes we used TIRF microscopy to sequentially image DCF (i.e., ROS) and fluo-5F (i.e., Ca 2+ ) fluorescence. First we loaded arterial myocytes with the cell-permeant ROS indicator DCF in Ca 2+ -free buffer for 20 minutes as described above. Following washout of excess DCF with Ca 2+ -free buffer, a patch pipette was lowered onto a candidate myocyte, a GΩ seal was established (cell-attached configuration), and angiotensin II (Ang II; 100 nmol/L) was applied to the external solution to stimulate ROS generation. Changes in DCF fluorescence were then monitored with 491 nm laser excitation. Upon visual confirmation of punctate elevations in DCF fluorescence (see Figure 7A , image 1), negative pressure was applied to the patch pipette to rupture the plasma membrane and dialyze the cell with the Ca 2+ indicator fluo-5F (whole-cell configuration). We then superfused the cell with the same external solution containing 20 mmol/L Ca 2+ (with no Ang II) used to record Ca 2+ sparklets described above and monitored for Ca 2+ sparklet activity (also with 491 nm laser excitation; see Figure 7A , image 2). Note that the markedly dissimilar kinetics of DCF fluorescence ( Figure 7A , time course i at right) and fluo-5F fluorescence ( Figure 7A , time course ii at right) demonstrate sufficient dilution of intracellular DCF during dialysis with fluo-5F to permit sequential usage of these two spectrally overlapping indicators under these experimental conditions.
ROS/ Ca
2+ sparklet colocalization analysis
The average distance between the peaks (pre-defined as the pixels of highest intensity) of ROS puncta and Ca 2+ sparklet sites was 0.91 ± 0.24 µm (n = 6 sites from 5 cells). The probability, by chance alone, that we would observe 6 ROS puncta and 6 Ca 2+ sparklet sites approximately 1 µm apart is less than 1 in 1,000,000. We reached this value with the following approach: On average, the cell area imaged in our ROS/Ca 2+ sparklet experiments was approximately 100 µm 2 . If this area is assumed to be a grid of 1µm x 1µm pixels then the chance of complete overlap between the peak ROS and Ca 2+ sparklet sites (i.e., they occur at the same pixel) would be 1 in 100. However, we found that the measured peaks between these two events were approximately 1 µm apart. Thus, we need to include the 8 pixels surrounding the ROS peak pixel in our estimation (now 9 pixels out of 100). Rounding up to 10 total pixels for convenience indicates that for each experiment the chance of observing a ROS puncta peak within 1 µm of a Ca 2+ sparklet site peak would be 10 per 100 pixels imaged (or 1:10). We found that Ca 2+ sparklet peaks were on average 1 µm away from ROS peaks (less than a 1:10 probability) in 6 independent recordings. Thus, the probability of such an observation by chance alone is at a minimum 0.1 to the sixth power, or P < 0.000001.
Immunohistochemistry
For our immunofluorescence studies we used a mouse monoclonal PKCα antibody (Abcam, Cambridge, MA) with an Alexa Fluor 488-conjugated rabbit anti-mouse secondary antibody (Invitrogen, Carlsbad, CA) as used previously 6, 7 . Freshly prepared cerebral arterial myocyte suspensions were pipetted onto cover slips and the cells allowed to adhere for 20 minutes at room temperature. The adhered cells were then subjected in parallel to 20 minutes of either control or experimental conditions at room temperature in the same Ca 2+ -free buffer used for cell isolation. Cells were then fixed in 4 % formaldehyde for 10 minutes at room temperature, rinsed three times with phosphate buffered saline (PBS), and permeabilized with cooled (-80 °C) methanol for 10 minutes. Three methanol washes were applied with the final wash being allowed to evaporate. The fixed cells were then placed in blocking buffer (2% BSA in PBS) for 20 minutes and incubated overnight at 4°C with the PKCα (1:250) primary antibody. The next day cells were washed three times with blocking buffer and probed with secondary antibody [1:250] for 45 minutes at room temperature. Following three final washes with blocking buffer, the cover slips were mounted onto slides using UltraCruz™ mounting medium (Santa Cruz Biotechnology, Santa Cruz, CA). Images were obtained on a Zeiss LSM 510 Meta confocal microscope (Thornwood, NY). Excitation of the Alexa Fluor 488-conjugated secondary antibody was achieved with a 488 nm laser and excitation and emission light was separated with appropriate filters. Fluorescence was undetectable in control experiments where either the primary or the secondary antibody was omitted (data not shown). Membrane and cytosolic PKCα-associated fluorescence was quantified by measuring the intensity of pixels above a set threshold defined as the mean fluorescence intensity outside the cells (i.e., background) plus three times its standard deviation. For each cell analyzed, pixel intensities of the plasma membrane (≈ 1 µm in width) and a spatially equivalent section of cytosol were obtained and averaged. From these measurements, we determined the ratio of plasma membrane to cytosolic PKCα-associated fluorescence and used this as an indicator of PKCα translocation and activity as previously reported 6, 8 . Two-dimensional PKCα-associated fluorescence images were converted to three-dimensional surface plots with ImageJ (version 1.42q; National Institutes of Health, USA).
Chemicals and statistics
Supplemental Figure
Online currents in isolated cerebral arterial smooth muscle cells. A, Representative macroscopic L-type currents in response to a step depolarization to + 30 mV from a holding potential of -70 mV before and after XO plus HX (2mU/mL and 250 µmol/L, respectively) under control conditions (top) and in the presence of a PKC inhibitory peptide (PKCi; 100 µmol/L in the patch pipette; bottom). B, Plot of the mean ± SEM macroscopic L-type Ca 2+ current densities (pA / pF) before and after XO/HX under control conditions and in the presence of PKCi (n = 6 cells). C, Representative macroscopic L-type currents before and after Ang II (100 nmol/L) under control conditions (top) and in the presence of the NADPH oxidase inhibitor apocynin (25 µmol/L; bottom). D, Plot of the mean ± SEM macroscopic L-type Ca 2+ current densities (pA / pF) before and after Ang II under control conditions and in the presence of apocynin (n = 5 cells). * P < 0.05
